INSIGHT photo 0 INSIGHT photo 1 INSIGHT photo 2 INSIGHT photo 3

Abstracts & Presentations

International Conferences

2016 International Conferences

(By conference, by month, by author)

IDWeek 2016, New Orleans, Louisiana, October 2016

Boatman J et al. Risk factors for low immune recovery among participants with CD4 counts > 500 cells/?L in the immediate antiretrovrial treatment (ART) group in Strategic Timing of AntiRetroviral Treatment (START) Trial who achieved viral suppression -- Abstract | Poster

Options IX for the Control of Influenza, Chicago, Illinois, August 2016

Dwyer D et al, Comparison of the outcomes of individuals with medically-attended influenza A and B infections enrolled in two international cohort studies (INSIGHT FLU002 and FLU003) over a six-year period: 2009-2015 -- Abstract | Slides

Simonsen L et al. A role for the INSIGHT clinical research network in rapid assessment of key clinical and epidemiological characteristics of a future pandemic -- Abstract | Slides

AIDS 2016, Durban, South Africa, July 2016

Arenas-Pinto A et al, Increased risk of suicidal behaviour with use of efavirenz: results from the START trial -- Abstract | Slides

Babiker A et al, The role of plasma HIV RNA and T cell subset counts/percent and ratio in explaining the benefit of immediate antiretroviral therapy (ART) initiation in HIV+ individuals with high CD4+ counts -- Abstract | Poster

Matthews G (Rockstroh J, presenting) et al, Non-invasive serum markers suggest benefit for early ART initiation on liver fibrosis progression within the START study -- Abstract | Poster

Mocroft A et al, Deferred antiretroviral therapy is associated with lower estimated glomerular filtration rate in HIV-positive individuals with high CD4 counts -- Abstract | Poster

Molina J-M et al, Who benefited most from immediate treatment in START? A subgroup analysis -- Abstract | Slides

Rodger A et al, Assessment of the impact of early ART on sexual behaviour in INSIGHT strategic timing of antiretroviral treatment (START) trial -- Abstract | Poster

ISPOR 21st Annual International Meeting, Washington DC, May 2016

Powers III JH et al, Evaluation of the performance properties of the influenza patient-reported outcomes instrument (FLU-PRO) -- Abstract | Poster

Conference on Retroviruses and Opportunistic Infections (CROI) 2016, Boston, Massachusetts, February 2016

Baker J et al, Changes in CVD risk factors with early and deferred ART in the START trial -- Abstract | Poster

Baker J et al, Early antiretroviral therapy does not improve vascular function: a START substudy -- Abstract | Slides | Video

Borges A et al, Immediate ART initiation reduces risk of infection-related cancer in HIV infection -- Abstract | Slides | Audio

Lifson A et al, Increased quality of life with immediate ART initiation: results from the START trial -- Abstract | Poster

O'Connor G et al, Effect of immediate ART on risk of severe bacterial infections: the START trial -- Abstract | Poster

INSIGHT Footer
Email Webmaster with questions or suggestions.